1. The plaintiff (appointed)'s claim is dismissed.

2. The costs of lawsuit shall be borne by the plaintiff (appointed party).

1. Basic facts

A. The Plaintiff and the designated parties are children of the deceased C (1922 students, hereinafter “the deceased”).

B. On January 24, 201, the Deceased, at around 19:30 on January 24, 201, had a last telephone conversation with his family members who are guardians, but at around 21:00, was found to be unable to speak at the home, and was escorted to the emergency room of the Defendant Hospital at around 22:4

C. The medical personnel of the Defendant Hospital conducted the brain dynasty test at around 23:57 to ascertain the brain dynasty, the right side hynasty, and the fynasty hynasty test at around 22:58 to estimate the brain dynasty in color. As a result of the brain dynasty test at around 22:58, the medical personnel of the Defendant Hospital observed the brain dynasty change (which can be suspected of the brain dynasty color of the brain dynasty dynasty or serious brain dynasty color of the brain dynasty) over the left side (which can be suspected of the brain dynasty dynasty dynasty color)

Therefore, the medical team of the Defendant Hospital did not consider that the deceased had a high risk of occurrence of cerebral dystrophism such as cerebral dystrophism, considering the fact that 3 hours have elapsed from 19:30 to 19:30 on the basis of telephone conversations with his guardian, and the age of the deceased, etc., and the treatment of the exclusive use of dystrophical dystrophism was performed on January 25, 201. The medical team of the Defendant Hospital started to administer hystrophin in order to alleviate the hystrophism caused by cerebral dystrophism.

However, on January 30, 201, the Deceased died at around 05:20 due to cerebral side aggravation.

E. The only treatment method existing up to now for the treatment and recovery of acute cerebrovascular patients, such as the deceased, is the re-convening method such as diversing the exclusive use of blood.

However, it is not a certificate of adaptation for all patients, but it causes more poor conditions for the treatment of re-related diseases depending on the patient.

On the other hand, the defendant hospital's medical team administered to the deceased with the purpose of preventing the blood transfer.